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Abstract
Experiments in the late 19th century sought to define the host specificity of the causative agents of tuberculosis in
mammals. Mycobacterium tuberculosis, the human tubercle bacillus, was independently shown by Smith, Koch, and von
Behring to be avirulent in cattle. This finding was erroneously used by Koch to argue the converse, namely that
Mycobacterium bovis, the agent of bovine tuberculosis, was avirulent for man, a view that was subsequently discredited.
However, reports in the literature of M. tuberculosis isolation from cattle with tuberculoid lesions suggests that the virulence
of M. tuberculosis for cattle needs to be readdressed. We used an experimental bovine infection model to test the virulence
of well-characterized strains of M. tuberculosis and M. bovis in cattle, choosing the genome-sequenced strains M. tuberculosis
H37Rv and M. bovis 2122/97. Cattle were infected with approximately 10
6 CFU of M. tuberculosis H37Rv or M. bovis 2122/97,
and sacrificed 17 weeks post-infection. IFN-c and tuberculin skin tests indicated that both M. bovis 2122 and M. tuberculosis
H37Rv were equally infective and triggered strong cell-mediated immune responses, albeit with some indication of
differential antigen-specific responses. Postmortem examination revealed that while M. bovis 2122/97–infected animals all
showed clear pathology indicative of bovine tuberculosis, the M. tuberculosis–infected animals showed no pathology.
Culturing of infected tissues revealed that M. tuberculosis was able to persist in the majority of animals, albeit at relatively
low bacillary loads. In revisiting the early work on host preference across the M. tuberculosis complex, we have shown M.
tuberculosis H37Rv is avirulent for cattle, and propose that the immune status of the animal, or genotype of the infecting
bacillus, may have significant bearing on the virulence of a strain for cattle. This work will serve as a baseline for future
studies into the genetic basis of host preference, and in particular the molecular basis of virulence in M. bovis.
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Introduction
Genome sequencing across the Mycobacterium tuberculosis complex
has underlined the remarkable genetic identity shown between the
constituent members, with for example Mycobacterium bovis and
Mycobacterium tuberculosis sharing greater than 99.95% identity at
the nucleotide level [1,2]. However this genetic identity contrasts
with the distinct host preference of the tubercle bacilli, which can
be seen as series of ecotypes marked by fixed molecular differences
[3]. This is evident from epidemiological data, with M. tuberculosis a
highly successful pathogen of humans, yet not able to sustain in
animal populations; the converse is true for M. bovis, a pathogen of
wild and domesticated mammals that rarely transmits between
immunocompetent humans. As the genome sequences of M. bovis
and M. tuberculosis are available, we should now be able to define
the genetic differences that lead to host tropism, and therefore to
define virulence factors that drive host preference across the
tubercle bacilli.
Theobald Smith was the first to describe differences between
human and bovine tubercle bacilli [4]. He described detailed
characterisation of two bacilli, one an isolate from a pet coati
whose owner had died from tuberculosis and which was taken as a
human isolate, the other an isolate from a tuberculous bull.
Inoculations of these bacilli into guinea pigs, rabbits and cattle
showed that the bovine culture was of greater virulence in the
animals tested, in particular cattle. Emil von Behring extended this
work, producing an attenuated M. tuberculosis strain by repeated
laboratory culture, and using this ‘‘bovo-vaccine’’ to vaccinate
cattle [5]. Robert Koch also investigated the virulence of M.
tuberculosis for cattle, describing in his 1901 address to the British
Congress of Tuberculosis [6] experimental infections of cattle
where human ‘‘tubercle bacilli or the sputum were injected under
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jugular vein. Six animals were fed with tuberculous sputum almost
daily for seven or eight months; four repeatedly inhaled great
quantities of bacilli.’’ The results of these infections were that
‘‘none of these cattle (there were nineteen of them) showed any
symptoms of disease and they gained considerably in weight. From
six to eight months after the beginning of the experiments they
were killed. In their internal organs not a trace of tuberculosis was
found’’ [6]. Hence early work on strain phenotypes indicated that
M. tuberculosis was avirulent in cattle.
However, it should be noted that the early virulence studies with
M. tuberculosis and M. bovis were limited by the techniques of the
day; e.g. strains of M. tuberculosis or M. bovis were not controlled
across laboratories; numbers of bacilli inoculated into experimen-
tal animals were not determined; growth conditions and growth
phase of the inoculum were ill-defined; and immunological read-
outs of infection were non existent. The need for rigorous
experimental assessment of the virulence of M. tuberculosis in cattle
is highlighted by our own isolation of M. tuberculosis from cattle in
Nigeria and Ethiopia [7,8] and by the work of others [9,10,11],
suggesting that the immune status of the animal, or genotype of
the infecting bacillus, may have significant bearing on the
‘‘virulence’’ of a strain.
In light of the completion of the genome sequences of M.
tuberculosis and M. bovis and the experimental advances since the
seminal studies of Smith, Koch and von Behring, it is now
opportune to revisit their early studies of human and tubercle
bacilli using the genome sequenced strains of M. bovis and M.
tuberculosis. In this report we describe the experimental infection of
cattle with the genome sequenced strains M. tuberculosis H37Rv
and M. bovis AF2122/97, and describe pathological and
immunological differences in cattle infected with these strains.
The differences between the virulence of these hallmark members
of the M. tuberculosis complex for cattle will serve as a baseline for
future studies into the genetic basis of host preference, and in
particular the molecular basis of virulence in M. bovis.
Material and Methods
Cattle
Approximately 6-month-old calves (Friesian or Friesian crosses,
castrated males) were obtained from bovine TB-free herds and
were accommodated in a high-level bio-secure facility at VLA.
Pre-selection IFN-g assays confirmed their disease-free status. All
cattle experiments were cleared by local ethical review and
animals procedures performed under a UK Home Office project
license within the conditions of the Animals (Scientific Procedures)
Act 1986.
Bacterial Strains
The M. bovis field isolate AF2122/97 was grown to mid-log
phase in Middlebrook 7H9 media (Difco, UK) supplemented with
10% (v/v) Middlebrook acid-albumin-dextrose-catalase enrich-
ment (Difco), 4.16 g/l sodium pyruvate (Sigma-Aldrich, UK) and
0.05% (v/v) Tween 80 (Sigma-Aldrich) and stocks stored frozen at
280uC. Stocks of M. tuberculosis H37Rv were prepared in the same
way except that the 7H9 media was supplement with 0.2% (v/v)
glycerol (Sigma-Aldrich) rather than sodium pyruvate. The colony
forming units (CFU)/ml of bacterial stocks was pre-determined by
bacterial enumeration of a serial dilution cultured on modified
Middlebrook 7H11 agar [12]. The virulence of both M. bovis
AF2122/97 and M. tuberculosis H37Rv stocks was confirmed via
inoculation of guinea pigs prior to the start of the cattle challenge
experiment, with both stocks clearly virulent in this model (data
not shown).
Experimental Schedule
Two groups of 5 calves were infected with either M. bovis (AF
2122/97) or M. tuberculosis (H37Rv) by endobronchial instillation
of 1.0610
6 and 2.8610
6 CFU respectively, as described previously
[13,14]. Blood samples were collected at regular intervals
throughout the challenge period. Blood sampling for one of the
M. bovis infected animals (2757) was only available up until week 5
post-infection since deterioration in the physical condition of this
animal was noted and it was euthanazed prematurely at week 6 on
animal welfare grounds. Post mortem examination, performed in
accordance with the protocol described below, identified extensive
miliary TB in this animal. The remaining animals were skin tested
with the single intradermal comparative cervical tuberculin test 16
weeks after M. bovis infection. The skin tests were performed as
specified in the European Economic Community Directive 80/
219EEC, amending directive 64/422/EEC, annex B.
Post-Mortem Examination
At the end of the experimental period (17 weeks post-infection),
calves were euthanazed by intravenous injection of sodium
pentabarbitone and a post mortem examination was performed.
Lungs were examined externally for the occurrence of lesions,
followed by slicing of the lung into 0.5- to 1-cm-thick sections that
were then individually examined for lesions. In addition, lymph
nodes of the head and pulmonary regions were removed. Lymph
nodes that were subject to detailed analysis always included the
submandibular, parotid, medial and lateral retropharyngeal,
tonsil, bronchial, cranial and caudal mediastinal and cranial
tracheobronchial lymph nodes. All major body organs were also
examined for evidence of disease. Lymph node tissues were sliced
into thin sections (1 to 2 mm thick) and examined for the presence
of visible lesions. Samples were collected for M. bovis culture (see
below) and also for histopathological examination (Ziehl-Neelsen
to stain for acid-fast bacilli and hematoxylin and eosin staining).
The severity of the gross pathological changes was scored using a
semi-quantitative scoring system as previously described [15]. In
summary, each of 7 lung lobes was scored from 0–5 depending on
the number of lesions and extent of pathology observed, 0 being
no pathology and 5 being extensive gross-coalescing lesions. The
lymph nodes of the upper and lower respiratory tract were
similarly scored but using a score of 0–3. The scores of the
individual lung lobes were added to calculate the lung score and of
the lymph nodes to calculate the lymph node score. Both lymph
node and pathology scores were combined to determine the total
pathology score per animal.
Bacterial Enumeration
Tissue sections collected at post mortem from lymph node and
lung samples were individually homogenized in 5 ml of sterile
phosphate buffered saline using a rotating-blade macerator system.
Enumeration of CFU/sample was performed by inoculating
modified 7H11 agar [12] plates with 50 ml of tissue homogenate
and counting colonies after incubation at 37uC for 4–6 weeks. A
semi-quantitative bacterial burden score of 0–4 was determined for
each tissue sample where 0=no colonies, 1=1–10 CFU, 2=11–
100 CFU, 3=101–1000 CFU and 4.1000 CFU per sample. The
score for all tissues was combined to provide a total bacteriology
burden score per animal. All culture positive samples from the M.
tuberculosis infected animals, and a representative sample from 4 of
the M. bovis infected cattle, were submitted to the VLA Molecular
Strain Typing Laboratory to confirm strain identity by spoligotyp-
TB Host Preference
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with minor modifications [8]. All culture positive samples isolated
from the cattle infected with M. tuberculosis had a spoligotype pattern
identical to the H37Rv infection strain whilst cultures from animals
infected with M. bovis only demonstrated a pattern identical to the
AF2122/97 strain (data not shown).
Antigens and Peptides
Bovine (PPD-B) and avian (PPD-A) tuberculins were supplied
by the Tuberculin Production Unit at VLA. For the skin-test,
PPD-A and PPD-B were used undiluted. PPD-B was used at a
concentration of 10 mg/ml in the IFN-c ELISPOT and TNF-a
ELISA assays. A cocktail of 21 overlapping peptides mapping the
entire sequence of both ESAT-6 and CFP-10 was used at a
concentration of 5 mg/ml per component peptide in the IFN-c
ELISPOT. Responses to Rv3879c were measured by IFN-c
ELISA using a pool of 10 synthetic peptides previously identified
to be recognised by M. bovis infected cattle [17].
IFN-c ELISPOT Assay
Direct enzyme-linked immunospots (ELISPOTs) were enumer-
ated as described previously [18] using a modification a protocol
for indirect ELISPOTs [19]. Briefly, ELISPOT plates (Immobi-
lon-P polyvinylidene difluoride membranes; Millipore, UK) were
coated overnight at 4uC with the bovine IFN-c specific
monoclonal antibody 2.2.1. Unbound antibody was removed by
washing, and the wells were blocked with 10% fetal calf serum in
RPMI 1640 medium (Life Technologies, UK). PBMC [2610
5/
well suspended in RPMI 1640 media supplemented with 5%
controlled process serum replacement type 3 (Sigma Aldrich)
nonessential amino acids (Sigma Aldrich) 5610
25M 2-mercapto-
ethanol, 100 U of penicillin/ml, and 100 mg of streptomycin
sulfate/ml (Sigma Aldrich)] were then added and cultured at 37uC
and 5% CO2 in a humidified incubator for 24 h. Spots were
developed with rabbit serum specific for IFN-c followed by
incubation with an alkaline phosphatase-conjugated monoclonal
antibody specific for rabbit immunoglobulin G (Sigma Aldrich).
The monoclonal antibody 2.2.1 was kindly supplied by D. Godson
(VIDO, Saskatoon, Saskatchewan, Canada). The spots were
visualized with 5-bromo-4-chloro-3-indolylphosphate–nitroblue
tetrazolium substrate (Sigma-Aldrich).
IFN-c ELISA
Whole-blood cultures were performed in 96-well plates in 0.2-
ml/well aliquots by mixing 0.1 ml of heparinized blood with an
equal volume of antigen diluted in RPMI 1640 supplemented
medium as described above. The supernatants were harvested
after 48 h of culture at 37uC and 5% CO2 in a humidified
incubator. The bovine IFN-c concentration was determined using
a commercially available kit (BOVIGAM
H ELISA, Prionics AG,
Switzerland).
TNF-a ELISA
PBMC (2610
5/well suspended in RPMI 1640 supplemented
media as described above) were cultured in the presence of antigen
for 6 days at 37uC and 5% CO2 in a humidified incubator.
Culture supernatants were harvested and the concentration of
bovine TNF-a determined using a commercially available kit
(Endogen, USA).
Statistical Analysis
Differences in cellular immune responses between M. bovis and
M. tuberculosis infection groups were compared at multiple post-
infection sampling points by non-parametric analysis using the 2-
way ANOVA test with Bonferroni post-test analysis. Difference in
pathological scoring parameters between groups was determined
using the Fisher Exact test, and differences between bacterial
burden scores and differences in skin-test responses were
compared using the non-parametric Mann-Whitney test with
Bonferroni post-test analysis. All statistical calculation were
performed using Prism 5 analysis software (Graphpad Inc. USA).
Results
Immune Responses in Cattle Infected with M. bovis or M.
tuberculosis
Infection of cattle via the intratracheal route was achieved using
1.0610
6 and 2.8610
6 of M. bovis and M. tuberculosis, respectively.
This resulted in specific IFN-c responses against PPD-B and an
ESAT-6/CFP-10 peptide mix developing in all animals starting
between one and two weeks post-infection (Figure 1A and B).
These responses were maintained throughout the experimental
period with no significant differences detectable between animals
infected with M. tuberculosis or M. bovis (Figure 1A and B).
Supporting these observations of strong and sustained cellular
immune responses induced by M. bovis or M. tuberculosis infection
are the results of the single intradermal comparative cervical
tuberculin test shown in Figure 1C. Both infectious agents induced
strong bovine PPD biased skin responses (Figure 1C). Interestingly,
while we observed stronger skin test responses to avian PPD in the
M. bovis infected animals compared to M. tuberculosis infection
(p=0.0317), the differential between PPD-A and PPD-B responses
between groups were not significantly different.
In addition to IFN-c responses we also measured in vitro TNF-a
responses after PBMC stimulation with bovine tuberculin.
Responses were measured by ELISA and are shown in Figure 2.
TNF-a production peaked 3 weeks post-infection and subsequent-
ly waned to background levels in both groups. However, the
responses of M. bovis infected animals were at this response peak
time point significantly higher compared to M. tuberculosis infected
animals (P,0.001, Figure 2).
We further measured in vitro IFN-c responses induced by a
number of antigen candidates prioritized as diagnostic reagents
(Cockle et al. 2002) including the RD1 antigen Rv3879c. Whilst
we could not detect response differences to other antigens tested
(as shown for ESAT-6 and CFP-10 in Figure 1B, with data for
others not shown), we observed a striking difference in the
responses to Rv3879c between M. bovis and M. tuberculosis infected
cattle in that T cells from the M. tuberculosis infected cattle did not
respond to stimulation with this antigen, whilst their counterparts
from M. bovis infected calves did (Figure 3). Although this
difference was apparent at almost all time-points tested, it reached
statistical significance at week 8 post-infection (P,0.01). Thus
both the differences in TNF-a production and the differences in T
cell specificity induced by the two pathogens suggested a different
outcome of infection which was assessed 17 weeks post-infection
by post-mortem examination (see next section).
Pathological and Microbiological Assessment of
Virulence
Of the M. bovis infected cattle, animals 2735 and 2756 showed
mild clinical signs of tuberculosis within the ethically acceptable
severity limit, while animal 2757 developed significant clinical
disease and had to be euthanazed after 6 weeks due to welfare
considerations. Seventeen weeks after infection, all remaining
animals were culled and detailed post-mortem examinations were
carried out. Pathology was scored using a semi-quantitative
TB Host Preference
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mortem examinations, it was clear that while M. bovis had caused
extensive gross pathology demonstrated by the presence of visible
lesions in the lungs and associated lymph nodes, cattle infected
with M. tuberculosis showed no pathological signs of disease
(Table 1). Statistically, these difference were highly significant for
the numbers of affected lung lobes and lung-associated lymph
nodes, as well as the lymph node, lung, and total pathology scores
(P,0.01). The bacterial culture results showed that while all M.
bovis infected animals were culture positive, only 3/5 cattle infected
with M. tuberculosis were culture positive (Table 1). In addition,
when we applied a culture score to describe bacterial loads in the
lymph nodes cultures, we also observed a significantly lower
bacterial burden (Table 1, p,0.01). Hence, it appears that while
M. tuberculosis was able to persist in the majority of animals at
relatively low bacillary loads, it was incapable of causing
pathology.
Figure 1. M. bovis and M. tuberculosis infection induces
comparable bovine cellular immune responses. Panels A and B;
Blood was collected at regulated intervals from cattle following
experimental infection with either M. bovis (n=5) or M. tuberculosis
(n=5). PBMCs were isolated and stimulated with bovine-PPD (panel A)
or a cocktail of peptides derived from ESAT-6 and CFP-10 (Panel B). The
number of antigen-specific cells expressing IFN-c was measured using
an ELISPOT assay. Data for each time point is presented as the mean
response 6 SEM with the no-antigen response subtracted. The
response in the M. tuberculosis infected cattle is shown as open circles
with a dotted line, and for the M. bovis infected cattle as closed triangles
with a solid line. Panel C; A tuberculin skin-test was performed at week
16 post-infection. The increase in skin induration was measured 72 hr
after administration of bovine (black bars) or avian (grey bars) PPD and
is presented as the mean 6 SEM.
doi:10.1371/journal.pone.0008527.g001
Figure 2. Elevated TNF-a responses in cattle infected with M.
bovis. Blood was collected from cattle following experimental infection
with either M. bovis (n=5) or M. tuberculosis (n=5). PBMCs were
isolated, stimulated with bovine-PPD and the expression of TNF-a
measured in the culture supernatant by ELISA. The response in the M.
tuberculosis infected cattle is shown as open circles with a dotted line,
and for the M. bovis infected cattle as closed triangles with a solid line.
Data for each time point is presented as the mean response 6 SEM with
the no-antigen response subtracted. Significant differences between
groups was determined using 2-way ANOVA with Bonferroni post-test
analysis (*** p,0.001).
doi:10.1371/journal.pone.0008527.g002
Figure 3. Differential recognition of Rv3879c by M. bovis
infected cattle. Blood was collected from cattle following experimen-
tal infection with either M. bovis (n=5) or M. tuberculosis (n=5). Whole
blood was stimulated with a pool of peptides derived from Rv3879c
and expression of IFN-c was measured by ELISA. The response in the M.
tuberculosis infected cattle is shown as open circles with a dotted line,
and for the M. bovis infected cattle as closed triangles with a solid line.
Data for each time point is presented as the mean response (OD450nm)
6 SEM with the no-antigen response subtracted. Significant differences
between groups was determined using 2-way ANOVA with Bonferroni
post-test analysis (** p,0.01).
doi:10.1371/journal.pone.0008527.g003
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It is well acknowledged that M. tuberculosis is a human-adapted
pathogen with an exquisite ability to infect and persist in human
populations. Infection of animals by M. tuberculosis has been
reported, but again it is generally accepted that this represents
spill-over of infection from humans to animals, and that animal
populations cannot sustain M. tuberculosis. This apparent attenu-
ation of M. tuberculosis in animal hosts is all the more intriguing
given that genome studies have shown us that the M. bovis genome
is merely a reduced version of the M. tuberculosis genome; hence, M.
bovis does not have any ‘‘virulence’’ loci for animals per se that have
been lost in M. tuberculosis. Instead it appears likely that differential
expression of a range of genes between M. tuberculosis and M. bovis
explains their specific host predilections.
We therefore sought to revisit the virulence of M. tuberculosis for
bovines using the genome sequenced type strain, M. tuberculosis
H37Rv, the best characterized strain of M. tuberculosis currently
available. As a control we used the M. bovis AF2122/97 strain, the
genome sequenced strain of M. bovis that we have used to develop
our bovine infection models. From our results it was clear that M.
tuberculosis H37Rv was avirulent in cattle; no pathological signs of
disease were evident in any of the infected cattle. This is despite the
fact that this same seed lot used to infect cattle was capable of
causing disease in guinea pigs (data not shown). Hence under
precise experimental conditions M. tuberculosis H37Rv and M. bovis
AF2122/97 have unambiguous phenotypic differences in cattle.
The immunological analysis of IFN-c and tuberculin skin test
responses, though, clearly indicated that both species are equally
infective and cause strong cell-mediated immune responses. The
reduced production of TNF-a in the M. tuberculosis H37Rv infected
cows is in agreement with the lack of visible pathology and reduced
virulence as TNF-a has been implicated in murine models in
formationand maintenance of granulomas(e.g. [20]). It has also not
escaped our notice that the model of M. tuberculosis infection of cattle
could constitute a potential animal model for human latency.
The difference seen in the recognition of Rv3879c between M.
bovis and M. tuberculosis infected animals is puzzling. Transcriptome
analysis of M. bovis and M. tuberculosis in vitro revealed no difference
in the expression of Rv3879c between the two strains [21]; studies
looking at intramacrophage gene expression of M. bovis and M.
tuberculosis in bovine alveolar macrophages also showed no
difference in Rv3879c expression (unpublished). Rv3879c is
known to show sequence variation between M. bovis and M.
tuberculosis [22], but the immunodominant epitopes do not map to
the variable region (data not shown), indicating that this is not the
reason for the differential recognition. Further investigation of the
differential recognition of antigens by M. tuberculosis and M. bovis
may shed light on the biological basis for this observation.
Isolation of M. tuberculosis from cattle in countries that include
India, Nigeria, Ethiopia and China [7,8,9,11] may point not only
to the weight of M. tuberculosis infection in these countries, but also
to the husbandry conditions and immune status of the cattle. It
appears therefore that distinct M. tuberculosis genotypes, or the
immune status of the animals, or a combination of these factors,
plays a major part in the outcome of infection of cattle with M.
tuberculosis.
The genetic basis for some of the key traits that differentiate M.
bovis from M. tuberculosis have now been deciphered, meaning that
we can construct recombinants where M. tuberculosis expresses
traits normally associated with M. bovis. Attractive candidates are
the antigens Mpb70 and Mpb83, proteins that are expressed at
much greater levels in M. bovis than in M. tuberculosis [23]. Behr and
colleagues have shown that these antigens are controlled by the
SigK regulon, and that M. bovis has a defective copy of the
negative regulator, the anti-SigK, leading to overexpression of
these antigens in M. bovis [24]. Furthermore, the Oryx bacillus
shows an independent mutation leading to SigK regulon
dysregulation, suggesting that overexpression of this particular
regulon may confer some selective advantage for infection of
animals [24]. Another factor that may confer a selective advantage
on M. bovis is mycoside B, a monosaccharide phenolic glycolipid
Table 1. With the exception of animals 2757, post mortems were performed 16 weeks post infection.
Animala Pathology
b Bacteriology
c
Lung Lymph Nodes Total Pathology
Lobes affected** Score** Head LNs Lung LNs** LN Score** Score** Score**
M. tuberculosis
2730 0 0 0 0 0 0 1
2731 0 0 0 0 0 0 5
2732 0 0 0 0 0 0 0
2733 0 0 0 0 0 0 6
2734 0 0 0 0 0 0 0
M. bovis
2723 3 11 2 3 14 25 27
2735 4 15 1 5 16 31 16
2736 2 9 0 2 3 12 15
2756 5 20 0 5 15 35 23
2757 7 30 4 5 24 34 55
Post mortem for 2757 was performed at week 6 post infection for reasons of animal welfare. The number of individual lung lobes and respiratory tract associated
lymph nodes with TB lesions is presented. The pathology score is based on a semi-quantitative assignment of disease severity within affected tissues as described in
the material and methods. Statistical difference between groups was determined using the Fisher Exact test (** p,0.01). Bacteriology score is based on the subtotal
of a semi-quantitative ranking of total CFU for each individual tissue homogenate as described in the material and methods. Statistical difference between groups
was determined using the Mann-Whitney test (** p,0.01).
doi:10.1371/journal.pone.0008527.t001
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[25,26]. It has previously been shown that the related, trisaccha-
ride PGL produced by Beijing strains of M. tuberculosis can act as
an immunomodulator [27]. Hence mycoside B may act to
manipulate the bovine immune response to M. bovis infection.
In conclusion, we have revisited some of the classic early work
on the infection of cattle with M. tuberculosis using an experimental
infection model and genome sequenced strains of M. tuberculosis
and M. bovis. This work sets the baseline for a dissection of the
virulence factors of M. bovis, and in defining a molecular basis for
host tropism in the M. tuberculosis complex.
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